Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GNRX

VanEck Vectors Generic Drugs ETF (GNRX) Price, Holdings, & News

About VanEck Vectors Generic Drugs ETF (NASDAQ:GNRX)

Advanced Chart

Key Stats

Today's Range
$22.42
$22.42
50-Day Range
$22.42
$22.42
52-Week Range
$20.17
$26.19
Volume
4 shs
Average Volume
1,310 shs
Market Capitalization
$3.36 million
Assets Under Management
$3.36 million
Dividend Yield
0.04%
Net Expense Ratio
0.57%
Aggregate Rating
N/A

ETF Overview

VanEck Vectors Generic Drugs ETF Expenses

TypeGNRXHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.50%0.56%0.56%0.54%0.53%
Other Expenses2.44%0.47%0.56%0.52%0.56%
Total Expense2.94%0.75%0.76%0.73%0.73%
Fee Waiver-2.37%-0.67%-0.66%-0.50%-0.63%
Net Expense0.57%0.60%0.63%0.63%0.60%
Receive GNRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Vectors Generic Drugs ETF and its competitors with MarketBeat's FREE daily newsletter.

GNRX ETF News Headlines

Amplify Weight Loss Drug & Treatment ETF (THNR)
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social Security? What we just discovered in Washington will stun even the most seasoned insiders.
GDIG ETF Stock Price History
VanEck Announces Changes to ETF Product Line
VanEck AEX UCITS ETF (TDT)
See More Headlines

GNRX ETF - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Vectors Generic Drugs ETF investors own include SLR Investment (SLRC), Saul Centers (BFS), Virtus LifeSci Biotech Products ETF (BBP), Bellevue Healthcare (BBH), Virtus LifeSci Biotech Clinical Trials ETF (BBC), ArrowMark Financial (BANX) and Yamana Gold (AUY).

Fund Details

Issuer
Van Eck
Fund Name
VanEck Vectors Generic Drugs ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:GNRX
Inception Date
1/12/2016
Fund Manager
Hao-Hung (Peter) Liao, Guo Hua (Jason) Jin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Indxx Global Generics & New Pharma Index
Category
Sector
Focus
Health Care
Development Level
Blended Development
Region
Global
Number of Holdings
0

Fund Statistics

Assets Under Management
$3.36 million
Average Daily Volume
$591.00
Discount/Premium
-0.42%

Administrator, Advisor and Custodian

Administrator
Van Eck Associates Corporation
Advisor
Van Eck Associates Corporation
Custodian
The Bank of New York Mellon Corporation
Distributor
Van Eck Securities Corporation
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Cantor Fitzgerald

Miscellaneous

Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

GNRX Sector Exposure

GNRX Industry Exposure


This page (NASDAQ:GNRX) was last updated on 7/28/2025 by MarketBeat.com Staff
From Our Partners